###### 

Patients demographic, anthropometric and HIV specific characteristics

                          MM−                 MM+                 P value
  ----------------------- ------------------- ------------------- ---------
  Total Number            665 (72.5%)         249 (27.5%)         --
  Women                   200 (30.1%)         48 (19.3%)          0.001
  Age                     47 (44-51)          52 (48-58)          \<0.001
  CDC C stage             147 (23.5%)         72 (29.5%)          0.037
  Smoking status                                                  0.001
  Non-smoker              376 (57.5%)         171 (69%)           
  \<10 cigarettes/day     105 (16.1%)         40 (16.1%)          
  \>10 cigarettes/day     173 (26.5%)         37 (14.9%)          
  Sedentary life          376 (57.5%)         171 (69%)           0.351
  No alcohol intake       349 (53.4%)         160 (34.5%)         0.002
  BMI                     23 (21--25)         24 (21-26)          0.010
  Fasting glucose         91 (86--98)         99 (89--114         \<0.001
  Triglycerides           139 (98--199)       164 (111--220)      0.028
  Total Cholesterol       199 (171--227)      196 (169--222)      0.481
  HDL Cholesterol         47 (38--57)         45 (36.53)          0.014
  HIV duration (months)   213 (149--300)      217 (174--273)      0.017
  CD4 nadir               210 (104--300)      172 71-284)         0.022
  Current CD4             652 (508--814)      628 (483--803)      0.538
  Current CD8             867 (650--1127)     890 (629--1200)     0.068
  Current CD4/CD8 ratio   0.76 (0.57--1.03)   0.76 (0.51--1.09)   0.489
  CD4/CD8 ratio strata                                            0.373
  \<0.8                   373 (56.1%)         136 (54.6%)         
  \>=0.8                  292 (43.9%)         113 (45.5%)         
  ARV initiation                                                  0.049
  PreART                  383 (58.1%)         157 (63.1%)         
  EarlyART                168 (25.5%)         67 (26.9%)          
  LateART                 108 (16.4%)         25 (10%)            
  Age at ARV initiation   36 (+-7)            41 (+-9)            0.001
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